Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones

C C Sanders1

  • 1Center for Research in Anti-Infectives and Biotechnology, Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, NE 68178, USA. ecsanders@earthlink.net

Insights

Quinolone resistance develops through stepwise mutations affecting drug targets, permeability, or efflux. Understanding this process allows prediction of effective therapies using an 8-fold rule to minimize resistance selection.

Area of Science:

  • Microbiology
  • Pharmacology
  • Genetics

Background:

  • Quinolone antibiotics are crucial for treating bacterial infections.
  • Resistance to quinolones is a growing public health concern.
  • Mechanisms of resistance involve mutations in chromosomal genes.

Purpose of the Study:

  • To elucidate the stepwise process of quinolone resistance development.
  • To identify patterns of cross-resistance and dichotomous resistance.
  • To develop a predictive rule for selecting effective quinolones and minimizing resistance.

Main Methods:

  • Analysis of mutation accumulation in bacterial chromosomal genes.
  • Quantification of susceptibility changes (4- to 8-fold) per mutation step.
  • Examination of cross-resistance patterns with different quinolones.
  • Evaluation of organism- and quinolone-specific resistance pathways.

Main Results:

  • Quinolone resistance evolves via a stepwise accumulation of mutations.
  • Each mutation typically reduces susceptibility by 4- to 8-fold.
  • Resistance pathways vary significantly based on the quinolone and organism.
  • Observed patterns include cross-resistance and dichotomous resistance.

Conclusions:

  • Understanding the stepwise evolution of quinolone resistance is key.
  • An '8-fold rule' can predict effective therapies and minimize resistance.
  • This knowledge aids in optimizing antibiotic treatment strategies.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...